List view / Grid view
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
6 May 2015 | By Victoria White
Dicerna Pharmaceuticals has presented positive preclinical data on its proprietary DsiRNA-EX Conjugate-mediated delivery technology at TIDES 2015...
27 April 2015 | By Victoria White
4DMT and Roche are to collaborate to discover and develop optimised next-generation AAV vectors for indications with high unmet medical need...
24 April 2015 | By Victoria White
AstraZeneca and Celgene collaborate for the development and commercialisation of MEDI4736 across a range of blood cancers, including non-Hodgkin’s lymphoma...
23 April 2015 | By Victoria White
Cytori Therapeutics presented data from two preclinical studies at ABA2015. The findings provide greater detail on Cytori's cell therapies...
23 April 2015 | By Victoria White
Dimension Therapeutics is advancing programmes to treat two rare diseases with often devastating outcomes for patients - OTC deficiency and GSDIa...
21 April 2015 | By Victoria White
Transgene has announced that new preclinical data for two of its programmes – TG4010 and TG3003 – were presented at the Annual Meeting of the AACR...
7 April 2015 | By Victoria White
Bristol-Myers Squibb get exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases...
31 March 2015 | By Victoria White
Norvatis and Aduro have entered an alliance that is focused on the discovery of cancer immunotherapies and launched a new immuno-oncology research group...
31 March 2015 | By Victoria White
Merck Serono and Intrexon Corporation have announced an exclusive collaboration and license agreement to develop and commercialise CAR-T cancer therapies...
30 March 2015 | By Victoria White
CRT and BioInvent have announced the start of a two-year research collaboration with leading antibody researchers at the University of Southampton...
26 March 2015 | By Victoria White
Scientists have revealed a brand new function for one of the first cancer genes ever discovered – the retinoblastoma gene...
24 March 2015 | By Victoria White
Semma, a company developing cell therapy for T1D, announces that it has closed a $44 million Series A consisting of equity financing and strategic funding...
20 March 2015 | By Victoria White
Prothena has announced positive results from a study of PRX002, a monoclonal antibody for the potential treatment of Parkinson's disease...
6 March 2015 | By The Medical Research Council
A pioneering new combined cell-gene therapy to treat lung cancer will be tested in NHS patients this year, after receiving £2m of Biomedical Catalyst funding from the Medical Research Council...
26 February 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced data supporting the clinical development of BMS-955176, an investigational component designed to prevent the maturation of HIV-1...
